Insight Molecular Diagnostics Inc.
IMDXNasdaq
$4.74
↑ +0.6%Jul 17 close · end-of-day
Price
1Y↑ +67.5%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$163.6M
Enterprise Value
$135.4M
P/E
—
P/S
84.0
P/B
—
EV/EBITDA
—
PEG
—
FCF Yield
-16.8%
Dividend Yield
—
Revenue (TTM)
$1.9M
Net Income (TTM)
$2.3M
Free Cash Flow (TTM)
-$27.5M
Gross Margin
50.7%
Operating Margin
-2500.7%
Net Margin
119.6%
ROE
-21.8%
ROIC
—
Debt / Equity
—
Net Cash
$28.2M
Return 1Y
+67.5%
Company profile
OncoCyte Corporation researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support services.
- CEO
- Joshua Riggs
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 120
- Headquarters
- California
- Website
- oncocyte.com
Management & directors
- James Andrea S.Chief Financial Officer
- Liu James YangVP ACCT, Cntlr, Treasurer, PAO
- Riggs JoshCEO and President
Roles derived from SEC Form 4 filings.
Earnings
IMDX Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$32,000.00↓ -98.5%
Diluted EPS-$0.12↓ -53.8%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $1.2M | $2.2M | $958,000.00 | $1.5M | $1.9M | $4.1M |
| Gross profit | -$639,000.00 | $1.4M | -$18,000.00 | $413,000.00 | $740,000.00 | $2.3M |
| Operating income | -$29.7M | -$53.7M | -$18.0M | -$25.1M | -$61.0M | -$51.1M |
| Net income | -$29.9M | -$64.1M | -$72.9M | -$27,781.00 | -$60,663.00 | -$50,222.00 |
| Diluted EPS | — | — | -$13.25 | -$3.75 | -$4.66 | -$1.65 |
| Operating cash flow | -$26.0M | -$35.9M | -$45.6M | -$23.3M | -$20.7M | -$22.2M |
| Free cash flow | -$27.2M | -$38.2M | -$49.9M | -$23.6M | -$21.2M | -$25.4M |
| Gross margin | -52.5% | 64.6% | -1.9% | 27.5% | 39.3% | 56.7% |
| Operating margin | -2443.3% | -2444.3% | -1878.6% | -1672.4% | -3245.1% | -1260.8% |
| Net margin | -2461.5% | -2916.2% | -7609.8% | -1.8% | -3.2% | -1.2% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $104,000.00 | $115,000.00 | $1.5M | $2.1M | $518,000.00 | $260,000.00 | $1.1M | $32,000.00 |
| Gross profit | $50,000.00 | $50,000.00 | $595,000.00 | $1.3M | $350,000.00 | $139,000.00 | $484,000.00 | $15,000.00 |
| Operating income | -$4.6M | -$13.5M | -$33.6M | -$6.8M | -$9.8M | -$11.0M | -$23.4M | -$4.4M |
| Net income | -$4.5M | -$13.5M | $27.1M | -$6.7M | -$9.7M | -$10.9M | $27.2M | -$4.3M |
| Diluted EPS | -$0.36 | -$0.98 | -$2.19 | -$0.26 | -$0.30 | -$0.34 | -$0.75 | -$0.12 |
| Operating cash flow | -$6.0M | -$5.5M | -$5.4M | -$5.8M | -$6.3M | -$4.5M | -$5.5M | -$7.6M |
| Free cash flow | -$6.2M | -$5.6M | -$5.6M | -$6.1M | -$6.6M | -$5.6M | -$7.0M | -$8.3M |
| Gross margin | 48.1% | 43.5% | 40.0% | 62.0% | 67.6% | 53.5% | 42.5% | 46.9% |
| Operating margin | -4453.8% | -11752.2% | -2262.9% | -318.0% | -1900.0% | -4249.2% | -2057.5% | -13790.6% |
| Net margin | -4355.8% | -11733.0% | 1823.1% | -312.0% | -1880.7% | -4174.6% | 2389.5% | -13406.3% |
Company news
Jun 29, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-01 | Arno Andrew | Tax withholding | 12,100 | $5.69 | $68,849.00 | filing |
| 2026-07-01 | SILVERMAN LOU | Tax withholding | 7,700 | $5.69 | $43,813.00 | filing |
| 2026-07-01 | Last Andrew J. | Tax withholding | 7,700 | $5.69 | $43,813.00 | filing |
| 2026-06-11 | SILVERMAN LOU | Award | 26,943 | $0.00 | $0.00 | filing |
| 2026-06-11 | Last Andrew J. | Award | 26,943 | $0.00 | $0.00 | filing |
| 2026-06-11 | Arno Andrew | Award | 32,331 | $0.00 | $0.00 | filing |
| 2026-04-27 | BROADWOOD PARTNERS LP | Buy | 250,923 | $3.64 | $913,133.89 | filing |
| 2026-04-27 | BROADWOOD PARTNERS LP | Buy | 0 | $0.00 | $0.00 | filing |
| 2026-04-24 | BROADWOOD PARTNERS LP | Buy | 38,880 | $3.53 | $137,083.10 | filing |
| 2026-04-24 | BROADWOOD PARTNERS LP | Buy | 0 | $0.00 | $0.00 | filing |
| 2026-04-23 | BROADWOOD PARTNERS LP | Buy | 280,381 | $3.50 | $982,034.45 | filing |
| 2026-04-23 | BROADWOOD PARTNERS LP | Buy | 0 | $0.00 | $0.00 | filing |
| 2026-04-20 | BROADWOOD PARTNERS LP | Buy | 40,690 | $3.88 | $157,966.72 | filing |
| 2026-04-20 | BROADWOOD PARTNERS LP | Buy | 0 | $0.00 | $0.00 | filing |
| 2026-04-17 | BROADWOOD PARTNERS LP | Buy | 40,114 | $3.57 | $143,251.11 | filing |
| 2026-04-17 | BROADWOOD PARTNERS LP | Buy | 0 | $0.00 | $0.00 | filing |
| 2026-04-16 | BROADWOOD PARTNERS LP | Buy | 102,057 | $3.45 | $351,657.80 | filing |
| 2026-04-16 | BROADWOOD PARTNERS LP | Buy | 0 | $0.00 | $0.00 | filing |
| 2026-03-26 | Riggs Josh· CEO and President | Tax withholding | 12,310 | $4.11 | $50,594.10 | filing |
| 2026-03-26 | James Andrea S.· Chief Financial Officer | Tax withholding | 11,298 | $4.11 | $46,434.78 | filing |
| 2026-03-26 | Liu James Yang· VP ACCT, Cntlr, Treasurer, PAO | Tax withholding | 2,578 | $4.11 | $10,595.58 | filing |
| 2026-03-26 | Liu James Yang· VP ACCT, Cntlr, Treasurer, PAO | Option exercise | 6,289 | — | — | filing |
| 2026-03-26 | James Andrea S.· Chief Financial Officer | Option exercise | 28,302 | — | — | filing |
| 2026-03-26 | Riggs Josh· CEO and President | Option exercise | 47,170 | — | — | filing |
| 2026-02-10 | BROADWOOD PARTNERS LP | Buy | 521,739 | $5.75 | $3.0M | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.